Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

VistaGen Therapeutics Inc Share Price

VTGN

NAQ

$0.518

-$0.03

(-5.52%)

Industry: Biotechnology Sector: Health Care

VistaGen Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

VistaGen Therapeutics Inc Share Price Chart

VistaGen Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$21.47M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

701.26K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.29

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$0.54 L

$5.14 H

$0.518

About VistaGen Therapeutics Inc, Common Stock

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase II clinical trial to treat major depressive disorder. It also develops PH80, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase II clinical trial for the treatment of vasomotor symptoms, including hot flashes due to menopause, premenstrual dysphoric disorder, and other women's health disorders; PH15, an investigational pherine nasal spray, which is in Phase II clinical trial for the treatment to improve cognitive impairment caused by mental fatigue and potentially other disorders; PH284, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase II clinical trial to treat loss of appetite associated with chronic disorders, such as cancer or heart disease, as well as cachexia; and AV-101, an oral prodrug that targets N-methyl-D-aspartate receptor in the brain for treating depression and neurological disorders. In addition, the company's clinical-stage pipeline consists of intranasal product candidates comprising pherines. It has a license and collaboration agreement with AffaMed Therapeutics, Inc. to develop, manufacture, and commercialize fasedienol for multiple anxiety-related disorders. Vistagen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

VistaGen Therapeutics Inc Stock Returns

Time Frame	VTGN	Sector	S&P500
1-Week Return	-10.89%	-0.87%	-0.87%
1-Month Return	-24.5%	-0.61%	0.27%
3-Month Return	-87.18%	6.68%	0.94%
6-Month Return	-81.32%	15.86%	9.31%
1-Year Return	-81.32%	4.52%	15.36%
3-Year Return	-93.96%	16.14%	67.39%
5-Year Return	-99.16%	34.02%	80.62%
10-Year Return	-99.77%	133.34%	261.57%

Time Frame	VTGN	Sector	S&P500
1-Week Return	-99.76%	-36.60%	-36.60%
1-Month Return	-96.73%	-7.17%	3.33%
3-Month Return	-99.98%	29.98%	3.87%
6-Month Return	-96.67%	34.79%	19.78%
1-Year Return	-81.32%	4.52%	15.36%
3-Year Return	-60.76%	5.11%	18.73%
5-Year Return	-61.55%	6.03%	12.55%
10-Year Return	-45.53%	8.84%	13.72%

VistaGen Therapeutics Inc Financials

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Revenue	1.09M	1.11M	(227.30K)	1.06M	486.00K	[{"date":"2021-03-31","value":98.25,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-20.5,"profit":false},{"date":"2024-03-31","value":95.95,"profit":true},{"date":"2025-03-31","value":43.83,"profit":true}]
Cost of Revenue	-	815.20K	509.80K	568.00K	635.00K	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":62.54,"profit":true},{"date":"2024-03-31","value":69.68,"profit":true},{"date":"2025-03-31","value":77.89,"profit":true}]
Gross Profit	1.09M	1.11M	(227.30K)	1.06M	486.00K	[{"date":"2021-03-31","value":98.25,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-20.5,"profit":false},{"date":"2024-03-31","value":95.95,"profit":true},{"date":"2025-03-31","value":43.83,"profit":true}]
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Operating Expenses	19.02M	48.89M	59.04M	34.09M	56.46M	[{"date":"2021-03-31","value":32.22,"profit":true},{"date":"2022-03-31","value":82.8,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":57.73,"profit":true},{"date":"2025-03-31","value":95.63,"profit":true}]
Operating Income	(17.93M)	(47.78M)	(59.27M)	(33.02M)	(55.97M)	[{"date":"2021-03-31","value":-1793380000,"profit":false},{"date":"2022-03-31","value":-4777890000,"profit":false},{"date":"2023-03-31","value":-5926800000,"profit":false},{"date":"2024-03-31","value":-3302100000,"profit":false},{"date":"2025-03-31","value":-5597300000,"profit":false}]
Total Non-Operating Income/Expense	4.20K	39.90K	52.40K	7.01M	9.12M	[{"date":"2021-03-31","value":0.05,"profit":true},{"date":"2022-03-31","value":0.44,"profit":true},{"date":"2023-03-31","value":0.57,"profit":true},{"date":"2024-03-31","value":76.92,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Pre-Tax Income	(17.93M)	(47.76M)	(59.24M)	(29.36M)	(51.41M)	[{"date":"2021-03-31","value":-1793160000,"profit":false},{"date":"2022-03-31","value":-4775900000,"profit":false},{"date":"2023-03-31","value":-5924180000,"profit":false},{"date":"2024-03-31","value":-2935800000,"profit":false},{"date":"2025-03-31","value":-5141100000,"profit":false}]
Income Taxes	2.60K	3.40K	5.90K	4.00K	7.00K	[{"date":"2021-03-31","value":37.14,"profit":true},{"date":"2022-03-31","value":48.57,"profit":true},{"date":"2023-03-31","value":84.29,"profit":true},{"date":"2024-03-31","value":57.14,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes	(17.93M)	(47.76M)	(59.25M)	(29.36M)	(51.42M)	[{"date":"2021-03-31","value":-1793420000,"profit":false},{"date":"2022-03-31","value":-4776240000,"profit":false},{"date":"2023-03-31","value":-5924770000,"profit":false},{"date":"2024-03-31","value":-2936200000,"profit":false},{"date":"2025-03-31","value":-5141800000,"profit":false}]

Income From Continuous Operations	(17.93M)	(47.76M)	(59.25M)	(29.36M)	(51.42M)	[{"date":"2021-03-31","value":-1793420000,"profit":false},{"date":"2022-03-31","value":-4776240000,"profit":false},{"date":"2023-03-31","value":-5924770000,"profit":false},{"date":"2024-03-31","value":-2936200000,"profit":false},{"date":"2025-03-31","value":-5141800000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	(17.93M)	(47.76M)	(59.25M)	(29.36M)	(51.42M)	[{"date":"2021-03-31","value":-1793420000,"profit":false},{"date":"2022-03-31","value":-4776240000,"profit":false},{"date":"2023-03-31","value":-5924770000,"profit":false},{"date":"2024-03-31","value":-2936200000,"profit":false},{"date":"2025-03-31","value":-5141800000,"profit":false}]

EPS (Diluted)	(0.39)	(0.25)	(1.98)	(2.07)	(1.67)	[{"date":"2021-03-31","value":-39,"profit":false},{"date":"2022-03-31","value":-25,"profit":false},{"date":"2023-03-31","value":-198,"profit":false},{"date":"2024-03-31","value":-207,"profit":false},{"date":"2025-03-31","value":-167,"profit":false}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Revenue	-	1.78%	(120.50%)	(568.10%)	(54.32%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-6767.13,"profit":false},{"date":"2024-03-31","value":-31904.59,"profit":false},{"date":"2025-03-31","value":-3050.79,"profit":false}]
Cost of Revenue	-	-	(37.46%)	11.42%	11.80%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":-317.6,"profit":false},{"date":"2024-03-31","value":96.78,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Profit	-	1.78%	(120.50%)	(568.10%)	(54.32%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-6767.13,"profit":false},{"date":"2024-03-31","value":-31904.59,"profit":false},{"date":"2025-03-31","value":-3050.79,"profit":false}]
Gross Margin	-	-	-	-	-	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Operating Expenses	-	156.99%	20.77%	(42.27%)	65.64%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":13.23,"profit":true},{"date":"2024-03-31","value":-26.92,"profit":false},{"date":"2025-03-31","value":41.81,"profit":true}]
Operating Income	-	166.42%	24.05%	(44.29%)	69.51%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":14.45,"profit":true},{"date":"2024-03-31","value":-26.61,"profit":false},{"date":"2025-03-31","value":41.77,"profit":true}]
Total Non-Operating Income/Expense	-	850.00%	31.33%	13285.50%	30.01%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":6.4,"profit":true},{"date":"2023-03-31","value":0.24,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":0.23,"profit":true}]
Pre-Tax Income	-	166.34%	24.04%	(50.44%)	75.12%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":14.45,"profit":true},{"date":"2024-03-31","value":-30.33,"profit":false},{"date":"2025-03-31","value":45.16,"profit":true}]
Income Taxes	-	30.77%	73.53%	(32.20%)	75.00%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":41.03,"profit":true},{"date":"2023-03-31","value":98.04,"profit":true},{"date":"2024-03-31","value":-42.94,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes	-	166.32%	24.05%	(50.44%)	75.12%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":14.46,"profit":true},{"date":"2024-03-31","value":-30.33,"profit":false},{"date":"2025-03-31","value":45.16,"profit":true}]

Income From Continuous Operations	-	166.32%	24.05%	(50.44%)	75.12%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":14.46,"profit":true},{"date":"2024-03-31","value":-30.33,"profit":false},{"date":"2025-03-31","value":45.16,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	-	166.32%	24.05%	(50.44%)	75.12%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":14.46,"profit":true},{"date":"2024-03-31","value":-30.33,"profit":false},{"date":"2025-03-31","value":45.16,"profit":true}]

EPS (Diluted)	-	(35.90%)	692.00%	4.55%	(19.32%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-5.19,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":0.66,"profit":true},{"date":"2025-03-31","value":-2.79,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	183.00K	234.00K	(15.00K)	244.00K	258.00K	[{"date":"2024-09-30","value":70.93,"profit":true},{"date":"2024-12-31","value":90.7,"profit":true},{"date":"2025-03-31","value":-5.81,"profit":false},{"date":"2025-06-30","value":94.57,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	157.00K	161.00K	161.00K	169.00K	-	[{"date":"2024-09-30","value":92.9,"profit":true},{"date":"2024-12-31","value":95.27,"profit":true},{"date":"2025-03-31","value":95.27,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	183.00K	234.00K	(15.00K)	75.00K	258.00K	[{"date":"2024-09-30","value":70.93,"profit":true},{"date":"2024-12-31","value":90.7,"profit":true},{"date":"2025-03-31","value":-5.81,"profit":false},{"date":"2025-06-30","value":29.07,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	100.00%	100.00%	100.00%	30.74%	100.00%	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":30.74,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	14.41M	15.35M	14.48M	15.88M	20.31M	[{"date":"2024-09-30","value":70.95,"profit":true},{"date":"2024-12-31","value":75.59,"profit":true},{"date":"2025-03-31","value":71.29,"profit":true},{"date":"2025-06-30","value":78.18,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	(14.23M)	(15.12M)	(14.49M)	(15.80M)	(20.05M)	[{"date":"2024-09-30","value":-1422700000,"profit":false},{"date":"2024-12-31","value":-1512000000,"profit":false},{"date":"2025-03-31","value":-1449500000,"profit":false},{"date":"2025-06-30","value":-1580400000,"profit":false},{"date":"2025-09-30","value":-2005300000,"profit":false}]
Total Non-Operating Income/Expense	2.55M	2.06M	1.72M	1.42M	1.27M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":80.99,"profit":true},{"date":"2025-03-31","value":67.36,"profit":true},{"date":"2025-06-30","value":55.77,"profit":true},{"date":"2025-09-30","value":49.73,"profit":true}]
Pre-Tax Income	(12.95M)	(14.09M)	(13.63M)	(15.10M)	(19.42M)	[{"date":"2024-09-30","value":-1295400000,"profit":false},{"date":"2024-12-31","value":-1408900000,"profit":false},{"date":"2025-03-31","value":-1363500000,"profit":false},{"date":"2025-06-30","value":-1509500000,"profit":false},{"date":"2025-09-30","value":-1941700000,"profit":false}]
Income Taxes	7.00K	(14.09M)	-	-	-	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-201271.43,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	(12.96M)	-	-	-	-	[{"date":"2024-09-30","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(12.96M)	(14.09M)	(13.63M)	(15.10M)	(19.42M)	[{"date":"2024-09-30","value":-1296100000,"profit":false},{"date":"2024-12-31","value":-1408900000,"profit":false},{"date":"2025-03-31","value":-1363500000,"profit":false},{"date":"2025-06-30","value":-1509500000,"profit":false},{"date":"2025-09-30","value":-1941700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(12.96M)	(14.09M)	(13.63M)	(15.10M)	(19.42M)	[{"date":"2024-09-30","value":-1296100000,"profit":false},{"date":"2024-12-31","value":-1408900000,"profit":false},{"date":"2025-03-31","value":-1363500000,"profit":false},{"date":"2025-06-30","value":-1509500000,"profit":false},{"date":"2025-09-30","value":-1941700000,"profit":false}]

EPS (Diluted)	(0.42)	(0.46)	(0.44)	(0.47)	(0.54)	[{"date":"2024-09-30","value":-42,"profit":false},{"date":"2024-12-31","value":-46,"profit":false},{"date":"2025-03-31","value":-44,"profit":false},{"date":"2025-06-30","value":-47,"profit":false},{"date":"2025-09-30","value":-54,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	27.87%	(106.41%)	(1726.67%)	5.74%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-381.83,"profit":false},{"date":"2025-06-30","value":-6195.69,"profit":false},{"date":"2025-09-30","value":20.59,"profit":true}]
Cost of Revenue	-	2.55%	-	4.97%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":51.27,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	27.87%	(106.41%)	(600.00%)	244.00%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":11.42,"profit":true},{"date":"2025-03-31","value":-43.61,"profit":false},{"date":"2025-06-30","value":-245.9,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	-	-	(69.26%)	225.33%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":-30.74,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	-	6.55%	(5.69%)	9.66%	27.91%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":23.47,"profit":true},{"date":"2025-03-31","value":-20.39,"profit":false},{"date":"2025-06-30","value":34.62,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	-	6.28%	(4.13%)	9.03%	26.89%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":23.35,"profit":true},{"date":"2025-03-31","value":-15.37,"profit":false},{"date":"2025-06-30","value":33.59,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(19.01%)	(16.83%)	(17.20%)	(10.85%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Pre-Tax Income	-	8.76%	(3.22%)	10.71%	28.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":30.6,"profit":true},{"date":"2025-03-31","value":-11.25,"profit":false},{"date":"2025-06-30","value":37.4,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	-	(201371.43%)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	8.70%	(3.22%)	10.71%	28.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":30.4,"profit":true},{"date":"2025-03-31","value":-11.25,"profit":false},{"date":"2025-06-30","value":37.4,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	8.70%	(3.22%)	10.71%	28.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":30.4,"profit":true},{"date":"2025-03-31","value":-11.25,"profit":false},{"date":"2025-06-30","value":37.4,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	-	9.52%	(4.35%)	6.82%	14.89%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":63.95,"profit":true},{"date":"2025-03-31","value":-29.19,"profit":false},{"date":"2025-06-30","value":45.78,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Assets
Current Assets	104.12M	71.00M	17.51M	120.67M	82.08M	[{"date":"2021-03-31","value":86.28,"profit":true},{"date":"2022-03-31","value":58.84,"profit":true},{"date":"2023-03-31","value":14.51,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":68.02,"profit":true}]
Non-current Assets	4.16M	3.65M	3.58M	2.98M	2.27M	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":87.55,"profit":true},{"date":"2023-03-31","value":86.03,"profit":true},{"date":"2024-03-31","value":71.59,"profit":true},{"date":"2025-03-31","value":54.4,"profit":true}]
Total Assets	108.28M	74.64M	21.09M	123.65M	84.34M	[{"date":"2021-03-31","value":87.57,"profit":true},{"date":"2022-03-31","value":60.37,"profit":true},{"date":"2023-03-31","value":17.05,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":68.21,"profit":true}]

Total Liabilities
Current Liabilities	4.19M	5.77M	4.57M	5.12M	12.61M	[{"date":"2021-03-31","value":33.21,"profit":true},{"date":"2022-03-31","value":45.71,"profit":true},{"date":"2023-03-31","value":36.27,"profit":true},{"date":"2024-03-31","value":40.62,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Liabilities	12.11M	4.16M	4.43M	4.24M	1.34M	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":34.37,"profit":true},{"date":"2023-03-31","value":36.61,"profit":true},{"date":"2024-03-31","value":35.03,"profit":true},{"date":"2025-03-31","value":11.05,"profit":true}]
Total Liabilities	16.30M	9.93M	9.01M	9.37M	13.95M	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":60.9,"profit":true},{"date":"2023-03-31","value":55.26,"profit":true},{"date":"2024-03-31","value":57.46,"profit":true},{"date":"2025-03-31","value":85.57,"profit":true}]

Total Shareholders' equity
Common Stock	180.80K	6.90K	7.00K	27.00K	29.00K	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":3.82,"profit":true},{"date":"2023-03-31","value":3.87,"profit":true},{"date":"2024-03-31","value":14.93,"profit":true},{"date":"2025-03-31","value":16.04,"profit":true}]
Retained Earnings	(219.84M)	(267.60M)	(326.85M)	(356.21M)	(407.63M)	[{"date":"2021-03-31","value":-21984160000,"profit":false},{"date":"2022-03-31","value":-26760400000,"profit":false},{"date":"2023-03-31","value":-32685200000,"profit":false},{"date":"2024-03-31","value":-35621400000,"profit":false},{"date":"2025-03-31","value":-40763200000,"profit":false}]
Other Stockholders' Equity	311.63M	332.31M	338.93M	470.47M	477.99M	[{"date":"2021-03-31","value":65.2,"profit":true},{"date":"2022-03-31","value":69.52,"profit":true},{"date":"2023-03-31","value":70.91,"profit":true},{"date":"2024-03-31","value":98.43,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Shareholders' equity	91.98M	64.72M	12.08M	114.29M	70.39M	[{"date":"2021-03-31","value":80.48,"profit":true},{"date":"2022-03-31","value":56.63,"profit":true},{"date":"2023-03-31","value":10.57,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":61.59,"profit":true}]

Total Liabilities & Shareholders Equity	108.28M	74.64M	21.09M	123.65M	84.34M	[{"date":"2021-03-31","value":87.57,"profit":true},{"date":"2022-03-31","value":60.37,"profit":true},{"date":"2023-03-31","value":17.05,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":68.21,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Assets
Current Assets	-	(31.81%)	(75.34%)	589.28%	(31.98%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-5.4,"profit":false},{"date":"2023-03-31","value":-12.79,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-5.43,"profit":false}]
Non-current Assets	-	(12.45%)	(1.74%)	(16.78%)	(24.02%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":null,"profit":false},{"date":"2023-03-31","value":null,"profit":false},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Total Assets	-	(31.07%)	(71.75%)	486.34%	(31.79%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-6.39,"profit":false},{"date":"2023-03-31","value":-14.75,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-6.54,"profit":false}]

Total Liabilities
Current Liabilities	-	37.62%	(20.66%)	12.00%	146.18%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":25.74,"profit":true},{"date":"2023-03-31","value":-14.13,"profit":false},{"date":"2024-03-31","value":8.21,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Liabilities	-	(65.63%)	6.53%	(4.31%)	(68.45%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-1004.54,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-65.91,"profit":false},{"date":"2025-03-31","value":-1047.63,"profit":false}]
Total Liabilities	-	(39.10%)	(9.26%)	3.97%	48.94%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-79.9,"profit":false},{"date":"2023-03-31","value":-18.92,"profit":false},{"date":"2024-03-31","value":8.12,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	(96.18%)	1.45%	285.71%	7.41%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-33.66,"profit":false},{"date":"2023-03-31","value":0.51,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":2.59,"profit":true}]
Retained Earnings	-	21.73%	22.14%	8.98%	14.43%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":98.13,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":40.57,"profit":true},{"date":"2025-03-31","value":65.2,"profit":true}]
Other Stockholders' Equity	-	6.64%	1.99%	38.81%	1.60%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":17.09,"profit":true},{"date":"2023-03-31","value":5.13,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":4.12,"profit":true}]
Total Shareholders' equity	-	(29.64%)	(81.33%)	846.08%	(38.41%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-3.5,"profit":false},{"date":"2023-03-31","value":-9.61,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-4.54,"profit":false}]

Total Liabilities & Shareholders Equity	-	(31.07%)	(71.75%)	486.34%	(31.79%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-6.39,"profit":false},{"date":"2023-03-31","value":-14.75,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-6.54,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	99.95M	89.94M	82.08M	66.72M	78.93M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":89.99,"profit":true},{"date":"2025-03-31","value":82.12,"profit":true},{"date":"2025-06-30","value":66.75,"profit":true},{"date":"2025-09-30","value":78.98,"profit":true}]
Non-current Assets	2.55M	2.37M	2.27M	2.21M	2.00M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":92.86,"profit":true},{"date":"2025-03-31","value":88.89,"profit":true},{"date":"2025-06-30","value":86.66,"profit":true},{"date":"2025-09-30","value":78.3,"profit":true}]
Total Assets	102.50M	92.31M	84.34M	68.92M	80.93M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":90.06,"profit":true},{"date":"2025-03-31","value":82.29,"profit":true},{"date":"2025-06-30","value":67.25,"profit":true},{"date":"2025-09-30","value":78.96,"profit":true}]

Total Liabilities
Current Liabilities	7.52M	9.62M	12.61M	11.15M	13.64M	[{"date":"2024-09-30","value":55.14,"profit":true},{"date":"2024-12-31","value":70.51,"profit":true},{"date":"2025-03-31","value":92.44,"profit":true},{"date":"2025-06-30","value":81.76,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	2.00M	1.56M	1.34M	1.00M	946.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":78.24,"profit":true},{"date":"2025-03-31","value":66.98,"profit":true},{"date":"2025-06-30","value":50.23,"profit":true},{"date":"2025-09-30","value":47.32,"profit":true}]
Total Liabilities	9.52M	11.19M	13.95M	12.16M	14.59M	[{"date":"2024-09-30","value":65.26,"profit":true},{"date":"2024-12-31","value":76.66,"profit":true},{"date":"2025-03-31","value":95.62,"profit":true},{"date":"2025-06-30","value":83.34,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	27.00K	28.00K	29.00K	29.00K	39.00K	[{"date":"2024-09-30","value":69.23,"profit":true},{"date":"2024-12-31","value":71.79,"profit":true},{"date":"2025-03-31","value":74.36,"profit":true},{"date":"2025-06-30","value":74.36,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(379.91M)	(394.00M)	(407.63M)	(422.73M)	(442.14M)	[{"date":"2024-09-30","value":-37990800000,"profit":false},{"date":"2024-12-31","value":-39399700000,"profit":false},{"date":"2025-03-31","value":-40763200000,"profit":false},{"date":"2025-06-30","value":-42272700000,"profit":false},{"date":"2025-09-30","value":-44214400000,"profit":false}]
Other Stockholders' Equity	472.83M	475.08M	477.99M	479.46M	508.43M	[{"date":"2024-09-30","value":93,"profit":true},{"date":"2024-12-31","value":93.44,"profit":true},{"date":"2025-03-31","value":94.01,"profit":true},{"date":"2025-06-30","value":94.3,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	92.97M	81.12M	70.39M	56.77M	66.34M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":87.25,"profit":true},{"date":"2025-03-31","value":75.71,"profit":true},{"date":"2025-06-30","value":61.05,"profit":true},{"date":"2025-09-30","value":71.35,"profit":true}]

Total Liabilities & Shareholders Equity	102.50M	92.31M	84.34M	68.92M	80.93M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":90.06,"profit":true},{"date":"2025-03-31","value":82.29,"profit":true},{"date":"2025-06-30","value":67.25,"profit":true},{"date":"2025-09-30","value":78.96,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(10.01%)	(8.74%)	(18.71%)	18.31%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-54.67,"profit":false},{"date":"2025-03-31","value":-47.75,"profit":false},{"date":"2025-06-30","value":-102.19,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	(7.14%)	(4.27%)	(2.52%)	(9.65%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(9.94%)	(8.63%)	(18.28%)	17.42%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-57.07,"profit":false},{"date":"2025-03-31","value":-49.55,"profit":false},{"date":"2025-06-30","value":-104.95,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	27.89%	31.09%	(11.55%)	22.31%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":89.71,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-37.16,"profit":false},{"date":"2025-09-30","value":71.77,"profit":true}]
Non-current Liabilities	-	(21.76%)	(14.39%)	(25.02%)	(5.78%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Liabilities	-	17.46%	24.73%	(12.84%)	19.99%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":70.62,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-51.94,"profit":false},{"date":"2025-09-30","value":80.85,"profit":true}]

Total Shareholders' equity
Common Stock	-	3.70%	3.57%	-	34.48%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":10.74,"profit":true},{"date":"2025-03-31","value":10.36,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	-	3.71%	3.46%	3.70%	4.59%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":80.74,"profit":true},{"date":"2025-03-31","value":75.34,"profit":true},{"date":"2025-06-30","value":80.62,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	0.48%	0.61%	0.31%	6.04%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":7.87,"profit":true},{"date":"2025-03-31","value":10.13,"profit":true},{"date":"2025-06-30","value":5.1,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	(12.75%)	(13.23%)	(19.36%)	16.87%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-75.58,"profit":false},{"date":"2025-03-31","value":-78.44,"profit":false},{"date":"2025-06-30","value":-114.77,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(9.94%)	(8.63%)	(18.28%)	17.42%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-57.07,"profit":false},{"date":"2025-03-31","value":-49.55,"profit":false},{"date":"2025-06-30","value":-104.95,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Operating Activities
Net Operating Cash Flow	(12.07M)	(45.26M)	(49.72M)	(25.81M)	(42.10M)	[{"date":"2021-03-31","value":-1207350000,"profit":false},{"date":"2022-03-31","value":-4525650000,"profit":false},{"date":"2023-03-31","value":-4971510000,"profit":false},{"date":"2024-03-31","value":-2581300000,"profit":false},{"date":"2025-03-31","value":-4209700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(275.40K)	(200.40K)	(740.30K)	(61.00K)	(13.15M)	[{"date":"2021-03-31","value":-27540000,"profit":false},{"date":"2022-03-31","value":-20040000,"profit":false},{"date":"2023-03-31","value":-74030000,"profit":false},{"date":"2024-03-31","value":-6100000,"profit":false},{"date":"2025-03-31","value":-1314800000,"profit":false}]

Financing Activities
Net Financing Cash Flow	114.10M	10.48M	(1.04M)	128.40M	3.21M	[{"date":"2021-03-31","value":88.86,"profit":true},{"date":"2022-03-31","value":8.16,"profit":true},{"date":"2023-03-31","value":-0.81,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":2.5,"profit":true}]

Net Change in Cash	101.75M	(34.97M)	(51.50M)	102.53M	(52.03M)	[{"date":"2021-03-31","value":99.24,"profit":true},{"date":"2022-03-31","value":-34.11,"profit":false},{"date":"2023-03-31","value":-50.23,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-50.75,"profit":false}]

Free Cash Flow
Free Cash Flow	(12.35M)	(45.46M)	(49.93M)	(25.87M)	(42.29M)	[{"date":"2021-03-31","value":-1234890000,"profit":false},{"date":"2022-03-31","value":-4545690000,"profit":false},{"date":"2023-03-31","value":-4992710000,"profit":false},{"date":"2024-03-31","value":-2587400000,"profit":false},{"date":"2025-03-31","value":-4228800000,"profit":false}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Operating Activities
Net Operating Cash Flow	-	274.84%	9.85%	(48.08%)	63.08%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":3.58,"profit":true},{"date":"2024-03-31","value":-17.49,"profit":false},{"date":"2025-03-31","value":22.95,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(27.23%)	269.41%	(91.76%)	21454.10%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-0.13,"profit":false},{"date":"2023-03-31","value":1.26,"profit":true},{"date":"2024-03-31","value":-0.43,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(90.81%)	(109.94%)	(12419.10%)	(97.50%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":null,"profit":false},{"date":"2023-03-31","value":null,"profit":false},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

Net Change in Cash	-	(134.37%)	47.25%	(299.09%)	(150.75%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-284.38,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-633,"profit":false},{"date":"2025-03-31","value":-319.05,"profit":false}]

Free Cash Flow
Free Cash Flow	-	268.10%	9.83%	(48.18%)	63.44%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":3.67,"profit":true},{"date":"2024-03-31","value":-17.97,"profit":false},{"date":"2025-03-31","value":23.66,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(10.89M)	(10.28M)	(10.06M)	(18.85M)	(13.76M)	[{"date":"2024-09-30","value":-1088600000,"profit":false},{"date":"2024-12-31","value":-1028000000,"profit":false},{"date":"2025-03-31","value":-1006200000,"profit":false},{"date":"2025-06-30","value":-1884600000,"profit":false},{"date":"2025-09-30","value":-1375900000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(7.79M)	(422.00K)	527.00K	(788.00K)	(94.00K)	[{"date":"2024-09-30","value":-1477.42,"profit":false},{"date":"2024-12-31","value":-80.08,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-149.53,"profit":false},{"date":"2025-09-30","value":-17.84,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	1.17M	1.95M	1.49M	27.65M	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":4.23,"profit":true},{"date":"2025-03-31","value":7.06,"profit":true},{"date":"2025-06-30","value":5.38,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	(18.67M)	(9.53M)	(7.58M)	(18.15M)	13.80M	[{"date":"2024-09-30","value":-135.29,"profit":false},{"date":"2024-12-31","value":-69.06,"profit":false},{"date":"2025-03-31","value":-54.95,"profit":false},{"date":"2025-06-30","value":-131.48,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(10.93M)	(10.28M)	(10.15M)	(18.91M)	(13.82M)	[{"date":"2024-09-30","value":-1092800000,"profit":false},{"date":"2024-12-31","value":-1028000000,"profit":false},{"date":"2025-03-31","value":-1015000000,"profit":false},{"date":"2025-06-30","value":-1891100000,"profit":false},{"date":"2025-09-30","value":-1381900000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(5.57%)	(2.12%)	87.30%	(26.99%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.38,"profit":false},{"date":"2025-03-31","value":-2.43,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-30.92,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(94.58%)	(224.88%)	(249.53%)	(88.07%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	-	66.61%	(23.73%)	1758.47%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":3.79,"profit":true},{"date":"2025-06-30","value":-1.35,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(48.96%)	(20.43%)	139.27%	(176.06%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-35.15,"profit":false},{"date":"2025-03-31","value":-14.67,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-126.42,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(5.93%)	(1.26%)	86.32%	(26.93%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.87,"profit":false},{"date":"2025-03-31","value":-1.47,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-31.2,"profit":false}]

VistaGen Therapeutics Inc Ratios

VistaGen Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	VTGN
Cash Ratio	5.66
Current Ratio	5.79

VistaGen Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	VTGN
ROA (LTM)	-44.62%
ROE (LTM)	-78.13%

VistaGen Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	VTGN
Debt Ratio Lower is generally better. Negative is bad.	0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.82

VistaGen Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	VTGN
Trailing PE	NM
Forward PE	NM
P/S (TTM)	31.74
P/B	0.33
Price/FCF	NM
EV/R	76.82
EV/Ebitda	NM
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is VistaGen Therapeutics Inc share price today?

VistaGen Therapeutics Inc (VTGN) share price today is $0.518

Can Indians buy VistaGen Therapeutics Inc shares?

Yes, Indians can buy shares of VistaGen Therapeutics Inc (VTGN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VTGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of VistaGen Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of VistaGen Therapeutics Inc (VTGN) via the Vested app. You can start investing in VistaGen Therapeutics Inc (VTGN) with a minimum investment of $1.

How to invest in VistaGen Therapeutics Inc shares from India?

You can invest in shares of VistaGen Therapeutics Inc (VTGN) via Vested in three simple steps:

Click on Sign Up or Invest in VTGN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in VistaGen Therapeutics Inc shares

What is VistaGen Therapeutics Inc 52-week high and low stock price?

The 52-week high price of VistaGen Therapeutics Inc (VTGN) is $5.14. The 52-week low price of VistaGen Therapeutics Inc (VTGN) is $0.54.

What is VistaGen Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of VistaGen Therapeutics Inc (VTGN) is

What is VistaGen Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of VistaGen Therapeutics Inc (VTGN) is 0.33

What is VistaGen Therapeutics Inc dividend yield?

The dividend yield of VistaGen Therapeutics Inc (VTGN) is 0.00%

What is the Market Cap of VistaGen Therapeutics Inc?

The market capitalization of VistaGen Therapeutics Inc (VTGN) is $21.47M

What is VistaGen Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of VistaGen Therapeutics Inc is VTGN

How Can Investors Use VistaGen Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of VistaGen Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether VistaGen Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from VistaGen Therapeutics Inc shares for Indian investors?

When investing in VistaGen Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the VistaGen Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare VistaGen Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of VistaGen Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that VistaGen Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

VistaGen Therapeutics Inc Share Price

VistaGen Therapeutics Inc Analyst Forecast

VistaGen Therapeutics Inc Share Price Chart

VistaGen Therapeutics Inc Key Stock Metrics

About VistaGen Therapeutics Inc, Common Stock

VistaGen Therapeutics Inc Stock Returns

VistaGen Therapeutics Inc Financials

VistaGen Therapeutics Inc Ratios

VistaGen Therapeutics Inc Liquidity Ratios

VistaGen Therapeutics Inc Asset Efficiency Ratios

VistaGen Therapeutics Inc Liability Ratios

VistaGen Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

VistaGen Therapeutics Inc Share Price

VistaGen Therapeutics Inc Analyst Forecast

VistaGen Therapeutics Inc Share Price Chart

VistaGen Therapeutics Inc Key Stock Metrics

About VistaGen Therapeutics Inc, Common Stock

VistaGen Therapeutics Inc Stock Returns

VistaGen Therapeutics Inc Financials

VistaGen Therapeutics Inc Ratios

VistaGen Therapeutics Inc Liquidity Ratios

VistaGen Therapeutics Inc Asset Efficiency Ratios

VistaGen Therapeutics Inc Liability Ratios

VistaGen Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²